Get the Stockscreener App
4.25
0.83%
0.03
After Hours:
4.25
Cargo Therapeutics Inc stock is traded at $4.25, with a volume of 788.30K.
It is up +0.83% in the last 24 hours and down -6.89% over the past month.
Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.
See More
Previous Close:
$4.22
Open:
$4.18
24h Volume:
788.30K
Relative Volume:
1.11
Market Cap:
$195.97M
Revenue:
-
Net Income/Loss:
$-147.71M
P/E Ratio:
-1.1853
EPS:
-3.5857
Net Cash Flow:
$-127.89M
1W Performance:
+3.78%
1M Performance:
-6.89%
6M Performance:
-76.60%
1Y Performance:
-77.21%
1-Day Range:
$4.095
$4.285
1-Week Range:
$4.08
$4.285
52-Week Range:
$3.00
$25.45
Cargo Therapeutics Inc Stock (CRGX) Company Profile
Name
Cargo Therapeutics Inc
Sector
Industry
Phone
650-499-8950
Address
835 INDUSTRIAL ROAD, SUITE 400, SAN CARLOS
Compare CRGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CRGX
Cargo Therapeutics Inc
|
4.25 | 189.06M | 0 | -147.71M | -127.89M | -3.5857 |
|
ONC
Beone Medicines Ltd Adr
|
245.58 | 25.81B | 3.81B | -644.79M | -669.77M | -6.24 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.85 | 111.46B | 11.10B | -988.90M | -1.26B | -3.92 |
|
AKTX
Akari Therapeutics Plc Adr
|
1.35 | 40.37M | 0 | 0 | 0 | 0.00 |
|
VRNA
Verona Pharma Plc Adr
|
81.16 | 6.19B | 0 | -153.72M | -103.81M | -2.00 |
|
REGN
Regeneron Pharmaceuticals Inc
|
489.52 | 64.44B | 14.09B | 4.50B | 2.96B | 39.28 |
Cargo Therapeutics Inc Stock (CRGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-30-25 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Jan-30-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Jan-30-25 | Downgrade | JP Morgan | Overweight → Underweight |
| Jan-30-25 | Downgrade | Jefferies | Buy → Hold |
| Jan-30-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jan-30-25 | Downgrade | Truist | Buy → Hold |
| Jan-30-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-26-24 | Initiated | William Blair | Outperform |
| Jul-22-24 | Initiated | H.C. Wainwright | Buy |
| Jul-08-24 | Initiated | Chardan Capital Markets | Buy |
| Jun-27-24 | Initiated | Piper Sandler | Overweight |
| Dec-05-23 | Initiated | JP Morgan | Overweight |
| Dec-05-23 | Initiated | Jefferies | Buy |
| Dec-05-23 | Initiated | TD Cowen | Outperform |
| Dec-05-23 | Initiated | Truist | Buy |
View All
Cargo Therapeutics Inc Stock (CRGX) Latest News
Deutsche Bank AG Increases Stake in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Pluri (NASDAQ:PLUR) vs. CARGO Therapeutics (NASDAQ:CRGX) Head-To-Head Review - Defense World
Northern Trust Corp Increases Stock Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Cargo Therapeutics stock rating cut by Jefferies to Hold - MSN
Top Executive Makes a Bold Move with CARGO Therapeutics Stock Sale! - TipRanks
CARGO Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
CARGO Therapeutics (CRGX) Projected to Post Earnings on Tuesday - Defense World
CARGO Therapeutics, Inc. Being Investigated on Behalf of CARGO Therapeutics, Inc. Investors. Contact Levi & Korsinsky For Details. - ACCESS Newswire
CARGO Therapeutics Inc expected to post a loss of 67 cents a shareEarnings Preview - TradingView
Truist cuts Cargo Therapeutics rating, slashes PT to $7 - MSN
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Shares Bought by MetLife Investment Management LLC - Defense World
Ratios in Focus: Analyzing CARGO Therapeutics Inc (CRGX)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Shares Bought by Wells Fargo & Company MN - Defense World
Barclays PLC Raises Stock Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
JPMorgan Chase & Co. Raises Stake in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Prepare Yourself for Liftoff: CARGO Therapeutics Inc (CRGX) - Sete News
CARGO Therapeutics Inc (NASDAQ: CRGX): Can A Stock Be -68.31% Lower Year-To-Date And Still Be A Loser? - Marketing Sentinel
Legal & General Group Plc Trims Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Examining the Potential Price Growth of CARGO Therapeutics Inc (CRGX) - knoxdaily.com
Ratio Analysis: Unpacking CARGO Therapeutics Inc (CRGX)’s Price-to-Cash and Price-to-Free Cash Flow - DWinneX
Press Release Distribution & PR Platform - ACCESS Newswire
Recent Insider Activity Could Benefit CARGO Therapeutics Inc (CRGX) - knoxdaily.com
What Has Been Going On With CARGO Therapeutics Inc (NASDAQ: CRGX) - Stocksregister
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Shares Acquired by Geode Capital Management LLC - Defense World
CARGO Therapeutics Inc’s (NASDAQ: CRGX) Stock Price Will Be Bearish Or Bullish In 2025 - Stocksregister
CRGX: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com
Q1 Biopharma Layoffs Hit California, Massachusetts Hard - BioSpace
Vanguard Group Inc. Purchases 22,286 Shares of CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
American Century Companies Inc. Invests $474,000 in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
CARGO Therapeutics, Inc. (NASDAQ:CRGX) Receives Consensus Rating of “Reduce” from Analysts - Defense World
Cargo Therapeutics executive Anup Radhakrishnan sells $6,522 in stock By Investing.com - Investing.com South Africa
Trial misses sink cancer stocks in Q1: Mersana, Cargo, Mural fall - BioWorld MedTech
Cargo Therapeutics executive Anup Radhakrishnan sells $6,522 in stock - Investing.com
Layoff Tracker: Relay Will Cut 70 Employees, Affecting Research Budget by 75% - BioSpace
Bronstein, Gewirtz & Grossman, LLC Encourages CARGO Therapeutics, Inc. (CRGX) Investors to Inquire about Securities Investigation - ACCESS Newswire
Swiss National Bank Boosts Stock Position in CARGO Therapeutics, Inc. (NASDAQ:CRGX) - Defense World
Brokers Offer Predictions for CRGX FY2025 Earnings - Defense World
Is CARGO Therapeutics (NASDAQ:CRGX) In A Good Position To Deliver On Growth Plans? - Yahoo Finance
Biotech company based in Peninsula laying off 90% of staff - MSN
Finance Watch: Cargo Restructuring Not The News The IPO Market Needs - insights.citeline.com
California-Based Biotech Therapeutics Firm Lays Off 90% of Workforce - NewsBreak: Local News & Alerts
Fierce Biotech Layoff Tracker 2025: Cargo lays off 90% of staff; Empress halves workforce - Fierce Biotech
Bay Area biotech company laying off 90% of staff as CEO leaves - San Francisco Chronicle
Bay Area biotech company, once worth $1.2 billion, lays off almost entire staff - SFGATE
CARGO THERAPEUTICS Earnings Preview: Recent $CRGX Insider Trading, Hedge Fund Activity, and More - Nasdaq
90% Workforce Reduction Sent This Small Cap Soaring - The Globe and Mail
CARGO Stock Surges 19% Pre-Market After Suspending Development, Cutting 90% of Workforce - GuruFocus.com
Cargo Therapeutics scraps R&D pipeline, axes bulk of workforce as it looks for an exit - Endpoints News
Cargo Therapeutics Inc Stock (CRGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Cargo Therapeutics Inc Stock (CRGX) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Radhakrishnan Anup | See Remarks |
Apr 03 '25 |
Sale |
4.00 |
1,629 |
6,522 |
77,317 |
| Chapman Gina | President & CEO |
Sep 18 '24 |
Option Exercise |
5.03 |
7,166 |
36,045 |
111,071 |
| Chapman Gina | President & CEO |
Sep 19 '24 |
Option Exercise |
5.03 |
2,975 |
14,964 |
106,880 |
| Chapman Gina | President & CEO |
Sep 18 '24 |
Sale |
25.09 |
7,166 |
179,775 |
103,905 |
| Chapman Gina | President & CEO |
Sep 19 '24 |
Sale |
25.03 |
2,975 |
74,457 |
103,905 |
| Radhakrishnan Anup | Chief Financial Officer |
Sep 18 '24 |
Option Exercise |
5.03 |
1,600 |
8,048 |
8,046 |
| Radhakrishnan Anup | Chief Financial Officer |
Sep 18 '24 |
Sale |
25.28 |
1,600 |
40,452 |
6,446 |
2.38%
1.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):